Sensei Biotherapeutics, Inc. reported a net loss of $21.1M in fiscal year 2025. This represents an increase of 30.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Sensei Biotherapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SNSE Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SNSE Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Sensei Biotherapeutics, Inc. financials
Frequently Asked Questions
What was Sensei Biotherapeutics, Inc.'s net income in fiscal year 2025?
Sensei Biotherapeutics, Inc. reported a net loss of $21.1M in fiscal year 2025.
How fast is Sensei Biotherapeutics, Inc.'s net income growing?
Sensei Biotherapeutics, Inc. (SNSE) net income rose by 30.1% year over year, from -$30.2M to -$21.1M in fiscal year 2025.
How has Sensei Biotherapeutics, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Sensei Biotherapeutics, Inc. (SNSE) net income went from -$20.1M in fiscal year 2020 to -$21.1M in fiscal year 2025.
What was Sensei Biotherapeutics, Inc.'s net income in the most recent quarter?
Sensei Biotherapeutics, Inc. (SNSE) reported -$170.2M in net income in Q1 2026. This represents a decrease of 2380.1% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Sensei Biotherapeutics, Inc. (SNSE) reported on that line in every period on record.